Welcome to MS Views and News blog

MS Views and News, empowers those affected by Multiple Sclerosis (MS) with educational information, resources and services. Please scroll downward to find articles or videos of interest, then click to open the document or video.

Categories

Latest Blog Posts

September 16, 2014

AbbVie, Biogen to file for FDA approval of MS drug (daclizumab), next year

  • MS Drug Therapies
    /
  • MS Research Study and Reports
    /
September 15, 2014 Phase-III results of the AbbVie-Biogen Idec experimental multiple sclerosis shot Zinbryta (daclizumab) indicate the drug bests Biogen’s…
MS Drug Therapies

September 16, 2014

Healthy’ Diets Don’t Seem to Reduce MS Risk

  • MS Research Study and Reports
    /
  • Multiple Sclerosis
    /
  • Nutrition
    /
Published: Sep 15, 2014 By John Gever, Managing Editor, MedPage Today Action Points Note that this study was published as an…
MS Research Study and Reports

September 16, 2014

Life from a Sitting Position – an MS patient’s story

  • An MS Patients Story
    /
by Richard M. Cohen on September 13, 2014 in JOURNEYMAN We have just about done this subject to death. Lots of attitudes and ap[p[roaches. Your…
An MS Patients Story

September 15, 2014

Sanofi (France), Genzyme’s Corporation Report Positive New Data From …

  • MS Drug Therapies
    /
  • MS Research Study and Reports
    /
9/11/2014  At Four Years, Treatment Effect Maintained in More Than Two-Thirds of Patients Who Received Genzyme’s Lemtrada in Pivotal Studies…
MS Drug Therapies

September 15, 2014

No Cognitive Disadvantage in Pediatric- vs Adult-Onset MS

  • MS Research Study and Reports
    /
Sept 11, 2014 BOSTON — A new study suggests no cognitive disadvantage in the long term for patients with multiple…
MS Research Study and Reports

September 15, 2014

Working Memory and Cognitive Reserve Linked in MS Kessler Foundation Study

  • Multiple Sclerosis (MS) Symptoms
    /
Any intervention that could help multiple sclerosis patients preserve long-term memory would likely be well-received. As suggested by a recent study from…
Multiple Sclerosis (MS) Symptoms

September 15, 2014

Plegridy Maintains Efficacy in Relapsing Multiple Sclerosis Trial

  • MS Drug Therapies
    /
  • Multiple Sclerosis
    /
September 11, 2014 Biogen Idec announced new data from the second year of its Phase 3 ADVANCE clinical trial for Plegridy (peginterferon beta-1a),…
MS Drug Therapies

September 15, 2014

Tecifdera Efficacious for Relapsing-Remitting Multiple Sclerosis

  • Multiple Sclerosis
    /
  • Oral MS Medications
    /
Biogen Idec announced five-year results from the ENDORSE Phase 3 extension study with Tecfidera(dimethyl fumarate) in patients with relapsing-remitting multiple sclerosis (RRMS). ENDORSE is…
Multiple Sclerosis

September 15, 2014

Mind, matter and multiple sclerosis

  • MS Research Study and Reports
    /
Confusion, agitation, panic can flood a person attempting a simple task By Chase Olivarius-McAllister Herald Staff Writer Have you seen…
MS Research Study and Reports

September 15, 2014

Undiagnosed sleep disorders common with MS

  • Multiple Sclerosis (MS) Symptoms
    /
The fatigue many people with multiple sclerosis (MS) experience may actually be a sign of an undiagnosed sleep disorder, according…
Multiple Sclerosis (MS) Symptoms

Categories

Latest Blog Posts